The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines

Yafei Liu(Second Affiliated Hospital of Nanjing Medical University), Hisashi Arase(Osaka International Cancer Institute), Atsushi Nakagawa(Kure Kyosai Hospital), Jun-ichi Kishikawa(Protein Research Foundation), Yoshiaki Yamagishi(Osaka University Hospital), Wataru Nakai(Osaka University), Akemi Arakawa(Osaka International University), Atsushi Kumanogoh(The University of Osaka), Noriko Arase(The University of Osaka), Mika Hirose(Protein Research Foundation), Hironori Nakagami(Osaka Health Science University), Takayuki Kato(Protein Research Foundation), Chikako Ono(The University of Osaka), Masato Okada(St. Luke's International Hospital), Asa Tada(Osaka International University), Yoshiharu Matsuura(Department of Virology), Songling Li, Hui Jin(The University of Osaka), Kazuki Kishida(The University of Osaka), Kanako Akamatsu(The University of Osaka), Masako Kohyama(Osaka International University), Daron M. Standley(The University of Osaka), Sumiko Matsuoka(The University of Osaka), Manabu Fujimoto(Osaka Gakuin University)
bioRxiv (Cold Spring Harbor Laboratory)
August 23, 2021
Cited by 38


Related Papers